Mayne Pharma Group Limited (ASX:MYX) Directors Insider Transactions



The Directors and Chief Executives of Mayne Pharma Group Limited (ASX:MYX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Mayne Pharma Group Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Mayne Pharma Group Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Mayne Pharma Group Limited Directors/Insider Transactions Activity

List of Insider trades activity from Mayne Pharma Group Limited (MYX).

Date Director Director's Title Shares Value Note
28 Feb 2026 Blake (Patrick J) Former 22,097 - -
18 Dec 2025 O'Brien (Shawn Patrick) Chief Executive Officer 196,716 - -
30 Jun 2025 Gray (A) Chief Financial Officer 81,691 - -
28 Feb 2025 Robinson (Bruce Gregory) Independent Non-Executive Director 15,103 - -
02 Sep 2024 O'Brien (Shawn Patrick) Chief Executive Officer 23,816 - -